BLES

Dosage

Children: Refer to specific drug guidelines as the term 'associated' does not refer to a single medication with a defined dosing regimen.

Adults: Refer to specific drug guidelines as the term 'associated' does not refer to a single medication with a defined dosing regimen.

Mechanism of action

The mechanism of action for drugs referred to as 'associated' varies widely. In pharmacology, drugs may act via several mechanisms including receptor agonism or antagonism, enzyme inhibition, or modulation of neurotransmitter release, depending on their specific pharmacological class and therapeutic use.

Pharmacodynamics

Pharmacodynamics of drugs termed 'associated' depend on the specific drug in question. Generally, pharmacodynamics examines the relationship between drug concentration and effect, which can include therapeutic effects and potential toxicity. This relationship is influenced by factors such as receptor affinity, intrinsic activity, and the drug's pharmacological profile.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of drugs. For drugs categorized as 'associated', these parameters will vary based on the specific compound. Key factors include bioavailability, half-life, volume of distribution, and clearance rates, which are critical for determining dosing regimens.

Pregnancy

The safety of associated in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether associated is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Lipid replacement therapy
• Nutritional supplementation
• Support in liver disease
• Support in skin conditions

Dosage

Children: Dosing for children should be determined by a healthcare provider, based on individual clinical circumstances and specific formulations.

Adults: Dosing of phospholipids varies widely based on specific formulations and clinical indications. It is essential to refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

Phospholipids serve as structural components of cell membranes, forming lipid bilayers that provide a barrier to the passage of ions and polar molecules. They also participate in cell signaling pathways, where they can be hydrolyzed to produce second messengers like diacylglycerol and inositol triphosphate, which are involved in various cellular processes.

Pharmacodynamics

Phospholipids influence membrane fluidity and permeability, affecting the function of membrane proteins and the interaction of cells with their environment. They also play a crucial role in the formation of lipid rafts, which are microdomains in the membrane that organize signaling molecules and facilitate cellular communication.

Pharmacokinetics

Phospholipids are absorbed from the gastrointestinal tract and are distributed throughout the body in various tissues. They undergo metabolic processes involving enzymatic hydrolysis and re-esterification, leading to the production of other lipids and bioactive molecules. The half-life and elimination pathways can vary depending on the specific type of phospholipid and its physiological role.

Pregnancy

Phospholipids are generally considered safe during pregnancy, as they are naturally occurring components of cell membranes and are involved in various physiological processes. However, specific formulations should be evaluated for safety.

Breast-feeding

Phospholipids are found in human milk and are deemed safe during breastfeeding. They play a role in infant nutrition and development.

Storage

Phospholipids should be stored in a cool, dry place, away from light. Specific storage conditions may vary based on the formulation.

Formulations

• Phosphatidylcholine
• Phosphatidylethanolamine
• Phosphatidylserine
• Phosphatidylinositol

Indications

• Nutritional supplementation
• Enzyme replacement therapy
• Hormonal therapies
• Immune modulation

Dosage

Children: Dosage of proteins for pediatric patients should be determined based on individual needs, specific conditions, and

Adults: Dosage of proteins varies widely based on the specific type of protein and its intended use. Refer to specific product guidelines for detailed dosing information.

Mechanism of action

Proteins function primarily as enzymes, structural components, signaling molecules, and transporters. Each protein has a unique sequence of amino acids that determines its specific shape and function. Enzymes, a class of proteins, facilitate biochemical reactions by lowering the activation energy required for the reactions to occur, thereby accelerating metabolic processes. The interaction of proteins with other molecules is often mediated through specific binding sites that recognize and bind to substrates, ligands, or other proteins.

Pharmacodynamics

The pharmacodynamic effects of proteins depend on their specific roles in biological systems. For instance, enzymes can enhance the rate of reactions, while structural proteins provide support and shape to cells and tissues. Hormonal proteins can influence various physiological processes by acting as signaling molecules that trigger specific cellular responses. The effectiveness of proteins in therapeutic applications often relies on their ability to bind specifically to target sites, leading to a desired physiological effect.

Pharmacokinetics

The pharmacokinetics of proteins can vary widely depending on their size, structure, and the presence of post-translational modifications. Generally, proteins are absorbed through the gastrointestinal tract when ingested, but their bioavailability may be limited due to digestion. When administered parenterally, proteins may have a more direct and rapid effect. They are typically metabolized by the liver and excreted primarily by the kidneys. The half-life of proteins can range significantly based on their molecular weight and the specific mechanisms of clearance.

Adverse effects

• Allergic reactions
• Anaphylaxis
• Gastrointestinal disturbances
• Immunogenic reactions

Precautions

• Use with caution in individuals with allergies to specific protein sources
• Monitor for allergic reactions when administered
• Consider potential interactions with other medications that may affect protein metabolism

Pregnancy

Proteins are essential nutrients during pregnancy, and adequate intake is necessary for fetal development. However, the source of protein should be carefully considered.

Breast-feeding

Proteins are vital for lactating mothers and their infants. Adequate protein intake supports both maternal health and milk production.

Storage

Store at room temperature in a cool, dry place away from direct sunlight. Refrigerate if specified for certain protein formulations.

Formulations

• Powdered protein supplements
• Liquid protein supplements
• Protein bars
• Intravenous protein formulations

Indications

• Neonatal respiratory distress syndrome (RDS)
• Prevention of atelectasis in premature infants
• Treatment of meconium aspiration syndrome

Dosage

Children: Refer to the BNF for Children for specific dosing protocols.

Mechanism of action

Surfactants act by reducing surface tension at the air-liquid interface within the alveoli, which prevents collapse during expiration and improves compliance of the lung tissue. The primary component, dipalmitoylphosphatidylcholine (DPPC), aligns at the surface, stabilizing the alveoli and promoting effective gas exchange. This mechanism is vital in conditions where surfactant deficiency occurs, such as neonatal RDS.

Pharmacodynamics

Surfactants enhance lung compliance, reduce the work of breathing, and improve oxygenation. By decreasing surface tension, they prevent the collapse of alveoli (atelectasis), leading to better ventilation and perfusion matching in the lungs. This results in improved gas exchange and reduced reliance on mechanical ventilation in neonates with RDS.

Pharmacokinetics

Surfactants are administered directly into the trachea, where they rapidly distribute throughout the alveolar surface. They are metabolized in the lungs and cleared via alveolar macrophages and the lymphatic system. The half-life varies based on formulation and individual patient factors, but they are generally cleared from the lungs within hours.

Adverse effects

• Respiratory distress
• Hypoxia
• Bradycardia
• Desaturation
• Pulmonary hemorrhage
• Air leak syndromes

Precautions

• Caution in patients with a history of lung disease
• Monitor for signs of respiratory distress post-administration
• Careful handling to avoid contamination

Pregnancy

Surfactants are generally considered safe for use during pregnancy when indicated.

Breast-feeding

Minimal risk to breastfeeding infants, but caution is advised.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze. Protect from light.

Formulations

• Poractant alfa (Curosurf)
• Beractant (Survanta)
• Calfactant (Infasurf)